Latest News

The Immune Tolerance Network today released updated results from its multicenter clinical trial of the Edmonton Protocol for islet transplantation. The results provide further confirmation that transplantation of pancreatic islet cells can safely and effectively eliminate the need for daily insulin injections in patients with type 1 diabetes. The expanded results, encompassing the entire cohort of 36 patients enrolled in the trial also confirms that the technique can be successfully applied at multiple clinical centers.